Vaxart, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $17.7M | $11.2M | $11.5M |
| FY2019 | — | $13.0M | $13.5M |
| FY2020 | — | $123.4M | $126.9M |
| FY2021 | — | $187.5M | $143.7M |
| FY2022 | — | $110.6M | $44.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $17.7M | $11.2M | $11.5M |
| FY2019 | — | $13.0M | $13.5M |
| FY2020 | — | $123.4M | $126.9M |
| FY2021 | — | $187.5M | $143.7M |
| FY2022 | — | $110.6M | $44.0M |